CClinicalTrials.gg
Not yet recruitingNCT06316375Updated Mar 27, 2024

STUMBL Score as a Risk Stratification Tool for Management of Blunt Chest Trauma Patients

An observational study in Blunt Injury of Thorax, sponsored by Assiut University. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-03-27.

Sponsored by Assiut University · Observational

From the registry’s dates

  • Primary completion was expected by Mar 2026, 6 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
200
Ages
18 Years and older
Sex
All
01

Study summary

The aim of this study is to assess validity of the STUMBL score in EGYPT for complications of blunt chest trauma without multi-trauma and immediate life-threatening injuries and identify patients at risk of in- hospital mortality or ICU admission and predict survival in both Assiut \& Suez Canal University Hospitals.

Read the detailed description

The STUMBL Score (STUdy of the Management of BLunt chest wall trauma) (also referred to as the Battle score) is a clinical prediction model that was developed and externally validated in 2014 in the UK . The purpose of the model is to assist in the clinical decision-making of patients with blunt chest wall trauma (excluding those with life-threatening injuries) in the Emergency Department (ED), through the calculation of a percentage risk of complications which in turn, provides a recommended discharge disposition. The STUMBL score includes five predictors: age at attendance, number of rib fractures, chronic lung disease, use of pre-injury anticoagulants and oxygen saturation (SpO2). This is the first score to introduce clinical variables, specifically chronic lung disease and anticoagulation, in contrast to other scores which have used anatomical variables and age alone. A huge benefit of the STUMBL score is that these variables are all routinely measured in the ED. Whilst other scores exist, the STUMBL Score is the only externally validated model with excellent predictive capabilities, that can be used for adult patients of all ages with blunt chest trauma presenting to the ED, not just a specific age group or severity of injury.

Collected data will be analyzed and tabulated by using appropriate statistical methods.

Statistical analysis will be performed by the SPSS statistical software computer program version 20 (Statistical Package for Social Science), Medcalc v.11.6.and Open Epi V.3.01.

Data will be described using mean ± standard deviation (SD) and frequencies according if they are quantitative or qualitative respectively.

Parametric tests will be used in the current study if data proved to be normally distributed.

For all statistical tests, a P value less than 0.05 will be taken to indicate a significant difference.

02

Conditions studied

  • Blunt Injury of Thorax

Keywords

  • Blunt chest trauma
  • STUMBL score
03

In context

Thoracic Injuries

84 studies on the registry are indexed under Thoracic Injuries; 23 are open to participants now.

This study's planned enrollment of 200 is above the median of 140 across 32 observational studies indexed under Thoracic Injuries.

Browse Thoracic Injuries studies →

Lead sponsor

Assiut University is the lead sponsor of 4,901 studies on the registry; 2,098 are open to participants now.

Of its 13 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

All patients with blunt chest trauma satisfying inclusion criteria and does not include exclusion criteria

Inclusion criteria

  • The present study will be conducted on patients of blunt chest trauma of both genders "without intently selected certain gender" and had 18 years old or more.

Exclusion criteria

Exclusion Criteria:

  • patients \<18 years of age
  • patients with life threatening conditions
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
200 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. The primary outcome was to assess the validity of the STUMBL score for all complications of chest blunt trauma, originally defined by the STUMBL authors

    These complications include: * In-hospital mortality. * All pulmonary complications (including but not restricted to haemothorax, pneumothorax, lung contusion, pneumonia, and empyema, excluding rib fractures). * Need for ICU admission. * Prolonged hospital stay defined as a total hospital stay of 7 days or more

    Time frame: 7 days

Secondary outcomes

  1. Secondary outcomes validated the STUMBL score using a composite of early and delayed complications.

    Early complications: * Presence of a pulmonary complication on arrival to ED as defined above * Admission to ICU from ED Delayed complications: * Delayed pulmonary complications defined as pulmonary complications developing or discovered after discharge from the ED to the ward or community,including lung contusion,pleural effusion,empyema, hemothorax,pneumothorax,pneumomediastinum,pneumonia or pulmonary embolism. * Delayed escalation in care,defined as a requirement for ICU admission because of chest trauma related complications at any point after discharge from the ED to the ward or community. * Unplanned re-presentation to the ED,Patient discharged from ED on the first presentation but re-presented to ED with complications of chest trauma that was not a planned followup assessment within 72h of discharge for patients whose initial hospital stay was 1day or less (including those discharged directly from ED and those admitted to a ward for less than 2days).

    Time frame: 72 hours

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 27, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06316375
Lead sponsor
Assiut University
Responsible party
hadeer mahmoud saber youssef (Emergency medicine resident, Assiut University) — Principal investigator
First posted
Mar 18, 2024
Start date
Apr 1, 2024 (estimated)
Primary completion
Mar 31, 2026 (estimated)
Completion
Apr 30, 2026 (estimated)
Last update
Mar 27, 2024

Study contacts

Hadeer Youssef, Mbbch
Contact
Hadeermahmoudsy@yahoo.com
01155101663 ext. +20

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Mar 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion